CNTACentessa Pharmaceuticals PLC - ADR

Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development PR Newswire NEW YORK...

Are SEM, UNF, CNTA, ASRT Obtaining Fair Deals for their Shareholders? Are SEM, UNF, CNTA, ASRT Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, May 19, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

Are CNTA, WSR, GDOT Obtaining Fair Deals for their Shareholders? Are CNTA, WSR, GDOT Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, May 12, 2026 Insiders may stand to receive...

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CLBK, NFBK, AFBI, and CNTA $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CLBK, NFBK, AFBI, and CNTA PR Newswire NEW YORK, May 11, 2026 NEW YORK, May 11, 2026 /PRNewswire...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Centessa Pharmaceuticals plc (NasdaqGS: CNTA...

LLY jumps after crushing Q1 estimates and raising 2026 outlook, powered by surging Mounjaro and Zepbound sales and strong global demand.

Centessa Pharmaceuticals (NASDAQ:CNTA) Sets New 52-Week High - Still a Buy...

Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA - Get Free Report) was the recipient of a significant drop in short interest in the month of April. As of April 15th, there was short interest totaling 3,468,688 shares, a drop of 47.5% from the March 31st total of 6,607,633 shares. Based on...

Eli Lilly made several multi-billion dollar acquisitions in 2026, with a strong focus on strengthening its oncology pipeline.